A single dose of an experimental CRISPR therapy cut LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders. The reductions were still present one year later, with the highest dose lowering LDL by 52.5% and triglycerides by 47.8%.
One CRISPR treatment cut “bad” cholesterol in half for a full year
Newsroom account for allfrontnews - world news from nine regions.
Leave a Comment
